Literature DB >> 23955460

Acute hepatitis with periportal confluent necrosis associated with human herpesvirus 6 infection in liver transplant patients.

Sophie Buyse1, Anne-Marie Roque-Afonso, Parissa Vaghefi, Michèle Gigou, Elisabeth Dussaix, Jean-Charles Duclos-Vallée, Didier Samuel, Catherine Guettier.   

Abstract

OBJECTIVES: To correlate human herpesvirus 6 (HHV-6) viral load with pathologic features in graft acute hepatitis of unknown origin.
METHODS: Liver frozen samples from 26 patients with graft hepatitis of unknown origin were available for HHV-6 DNA quantification.
RESULTS: In 10 (38.5%) of 26 liver samples, HHV-6 DNA was detectable, with a median viral load of 3.84 log10 copies/10⁶ cells. Confluent periportal necrosis was observed in 4 of 10 patients and associated with high viral load. These 4 patients responded to antiviral therapy. Mild unspecific hepatitis was observed in 4 patients with low intragraft viral load and in 2 patients with high viral load in a context of deep immunosuppression. Patients with HHV-6-negative graft hepatitis disclosed lobular necrotico-inflammatory activity without periportal necrosis.
CONCLUSIONS: Our study provides data supporting the pathogenic role of HHV-6 for liver allografts. The presence of confluent periportal necrosis could be a clue for prompt diagnosis of HHV-6-induced graft hepatitis.

Entities:  

Keywords:  Graft dysfunction; Graft hepatitis; Human herpesvirus 6; Liver transplantation

Mesh:

Substances:

Year:  2013        PMID: 23955460     DOI: 10.1309/AJCP0FWI2XAHECBJ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Fatal Myocarditis Associated With HHV-6 Following Immunosuppression in Two Children.

Authors:  Heather E Stefanski; Kathryn A Thibert; Joshua Pritchett; Bhupesh K Prusty; John E Wagner; Troy C Lund
Journal:  Pediatrics       Date:  2015-12-17       Impact factor: 7.124

Review 2.  Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials.

Authors:  Joshua A Hill; Danielle M Zerr
Journal:  Curr Opin Virol       Date:  2014-10-04       Impact factor: 7.090

Review 3.  Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature.

Authors:  J A Hill; D Myerson; R H Sedlak; K R Jerome; D M Zerr
Journal:  Transpl Infect Dis       Date:  2014-04-07       Impact factor: 2.228

Review 4.  Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus.

Authors:  Xin Wang; Shyam A Patel; Michael Haddadin; Jan Cerny
Journal:  Ther Adv Infect Dis       Date:  2021-05-24

Review 5.  Advances in the Characterization of the T-Cell Response to Human Herpesvirus-6.

Authors:  Derek J Hanson; Joshua A Hill; David M Koelle
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

Review 6.  Human herpesvirus 6B encephalitis in a liver transplant recipient: A case report and review of the literature.

Authors:  Yinfeng Wang; Di Wang; Xiaogen Tao
Journal:  Transpl Infect Dis       Date:  2020-07-21       Impact factor: 2.228

Review 7.  Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways.

Authors:  Wenjin Zheng; Qing Xu; Yiyuan Zhang; Xiaofei E; Wei Gao; Mogen Zhang; Weijie Zhai; Ronaldjit Singh Rajkumar; Zhijun Liu
Journal:  Virol J       Date:  2020-12-09       Impact factor: 4.099

8.  Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Tuan L Phan; Kristen Carlin; Per Ljungman; Ioannis Politikos; Vicki Boussiotis; Michael Boeckh; Michele L Shaffer; Danielle M Zerr
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-21       Impact factor: 5.742

9.  Investigation of Inherited Chromosomally Integrated Human Herpesvirus-6A+ and -6B+ in a Patient with Ulipristal Acetate-Induced Fulminant Hepatic Failure.

Authors:  Laure Izquierdo; Clémence M Canivet; Eleonora De Martin; Teresa M Antonini; Anne-Marie Roque-Afonso; Audrey Coilly; Claire Deback
Journal:  Viruses       Date:  2021-12-30       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.